BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 38607047)

  • 1. Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts.
    Pallotta MM; Di Nardo M; Musio A
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cohesin mutations are synthetic lethal with stimulation of WNT signaling.
    Chin CV; Antony J; Ketharnathan S; Labudina A; Gimenez G; Parsons KM; He J; George AJ; Pallotta MM; Musio A; Braithwaite A; Guilford P; Hannan RD; Horsfield JA
    Elife; 2020 Dec; 9():. PubMed ID: 33284104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohesin gene mutations in tumorigenesis: from discovery to clinical significance.
    Solomon DA; Kim JS; Waldman T
    BMB Rep; 2014 Jun; 47(6):299-310. PubMed ID: 24856830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanding phenotypes of cohesinopathies: one ring to rule them all!
    Piché J; Van Vliet PP; Pucéat M; Andelfinger G
    Cell Cycle; 2019 Nov; 18(21):2828-2848. PubMed ID: 31516082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic lethality of cohesins with PARPs and replication fork mediators.
    McLellan JL; O'Neil NJ; Barrett I; Ferree E; van Pel DM; Ushey K; Sipahimalani P; Bryan J; Rose AM; Hieter P
    PLoS Genet; 2012; 8(3):e1002574. PubMed ID: 22412391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers.
    van der Lelij P; Newman JA; Lieb S; Jude J; Katis V; Hoffmann T; Hinterndorfer M; Bader G; Kraut N; Pearson MA; Peters JM; Zuber J; Gileadi O; Petronczki M
    Life Sci Alliance; 2020 Jul; 3(7):. PubMed ID: 32467316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohesin mutations in human cancer.
    Hill VK; Kim JS; Waldman T
    Biochim Biophys Acta; 2016 Aug; 1866(1):1-11. PubMed ID: 27207471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers.
    Mondal G; Stevers M; Goode B; Ashworth A; Solomon DA
    Nat Commun; 2019 Apr; 10(1):1686. PubMed ID: 30975996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.
    Kon A; Shih LY; Minamino M; Sanada M; Shiraishi Y; Nagata Y; Yoshida K; Okuno Y; Bando M; Nakato R; Ishikawa S; Sato-Otsubo A; Nagae G; Nishimoto A; Haferlach C; Nowak D; Sato Y; Alpermann T; Nagasaki M; Shimamura T; Tanaka H; Chiba K; Yamamoto R; Yamaguchi T; Otsu M; Obara N; Sakata-Yanagimoto M; Nakamaki T; Ishiyama K; Nolte F; Hofmann WK; Miyawaki S; Chiba S; Mori H; Nakauchi H; Koeffler HP; Aburatani H; Haferlach T; Shirahige K; Miyano S; Ogawa S
    Nat Genet; 2013 Oct; 45(10):1232-7. PubMed ID: 23955599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic lethality and cancer: cohesin and PARP at the replication fork.
    O'Neil NJ; van Pel DM; Hieter P
    Trends Genet; 2013 May; 29(5):290-7. PubMed ID: 23333522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDS5A and PDS5B differentially affect gene expression without altering cohesin localization across the genome.
    Arruda NL; Bryan AF; Dowen JM
    Epigenetics Chromatin; 2022 Aug; 15(1):30. PubMed ID: 35986423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cohesin's ATPase activity couples cohesin loading onto DNA with Smc3 acetylation.
    Ladurner R; Bhaskara V; Huis in 't Veld PJ; Davidson IF; Kreidl E; Petzold G; Peters JM
    Curr Biol; 2014 Oct; 24(19):2228-37. PubMed ID: 25220052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paralogous synthetic lethality underlies genetic dependencies of the cancer-mutated gene
    Bailey ML; Tieu D; Habsid A; Tong AHY; Chan K; Moffat J; Hieter P
    Life Sci Alliance; 2021 Nov; 4(11):. PubMed ID: 34462321
    [No Abstract]   [Full Text] [Related]  

  • 14. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
    Atkinson JM; Rank KB; Zeng Y; Capen A; Yadav V; Manro JR; Engler TA; Chedid M
    PLoS One; 2015; 10(4):e0125028. PubMed ID: 25915038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-redundant roles in sister chromatid cohesion of the DNA helicase DDX11 and the SMC3 acetyl transferases ESCO1 and ESCO2.
    Faramarz A; Balk JA; van Schie JJM; Oostra AB; Ghandour CA; Rooimans MA; Wolthuis RMF; de Lange J
    PLoS One; 2020; 15(1):e0220348. PubMed ID: 31935221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDS5 proteins are required for proper cohesin dynamics and participate in replication fork protection.
    Morales C; Ruiz-Torres M; Rodríguez-Acebes S; Lafarga V; Rodríguez-Corsino M; Megías D; Cisneros DA; Peters JM; Méndez J; Losada A
    J Biol Chem; 2020 Jan; 295(1):146-157. PubMed ID: 31757807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells.
    Dasgupta T; Antony J; Braithwaite AW; Horsfield JA
    J Biol Chem; 2016 Jun; 291(24):12761-12770. PubMed ID: 27072133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle.
    Deardorff MA; Bando M; Nakato R; Watrin E; Itoh T; Minamino M; Saitoh K; Komata M; Katou Y; Clark D; Cole KE; De Baere E; Decroos C; Di Donato N; Ernst S; Francey LJ; Gyftodimou Y; Hirashima K; Hullings M; Ishikawa Y; Jaulin C; Kaur M; Kiyono T; Lombardi PM; Magnaghi-Jaulin L; Mortier GR; Nozaki N; Petersen MB; Seimiya H; Siu VM; Suzuki Y; Takagaki K; Wilde JJ; Willems PJ; Prigent C; Gillessen-Kaesbach G; Christianson DW; Kaiser FJ; Jackson LG; Hirota T; Krantz ID; Shirahige K
    Nature; 2012 Sep; 489(7415):313-7. PubMed ID: 22885700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low tolerance for transcriptional variation at cohesin genes is accompanied by functional links to disease-relevant pathways.
    Schierding W; Horsfield JA; O'Sullivan JM
    J Med Genet; 2021 Aug; 58(8):534-542. PubMed ID: 32917770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinase-dependent role for Haspin in antagonizing Wapl and protecting mitotic centromere cohesion.
    Liang C; Chen Q; Yi Q; Zhang M; Yan H; Zhang B; Zhou L; Zhang Z; Qi F; Ye S; Wang F
    EMBO Rep; 2018 Jan; 19(1):43-56. PubMed ID: 29138236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.